Publication | Closed Access

Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study

Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyImmune Checkpoint InhibitorImmunotherapyOncologyRadiation OncologyTreatment-naive Patients